MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model

This publication has 69 references indexed in Scilit:

• Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
  International Journal of Cancer, 2006
• Breaking down the barriers to cancer immunotherapy
  Nature Immunology, 2005
• Designer Glycopeptides for Cytotoxic T Cell–based Elimination of Carcinomas
  The Journal of Experimental Medicine, 2004
• Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment
  Blood, 2002
• CpG Motifs in Bacterial DNA and Their Immune Effects
  Annual Review of Immunology, 2002
• MUC1 peptide epitopes associated with five different H‐2 class I molecules
  European Journal of Immunology, 1997
• Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
  Immunology Today, 1996
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1992